Morning Briefing
Summaries of health policy coverage from major news organizations
Researchers To Wind Down HIV Prevention Trial In Women After Interim Results Find Drug Not Offering Protection From HIV
Researchers on Monday announced they were calling off a trial to test whether taking an oral HIV drug reduces the risk of HIV infection in women after interim analysis of the study showed women taking the medication were no less likely to become infected with HIV than those who were not taking the medicine, the Associated Press reports (4/18).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
